Share Facebook Twitter Pinterest Email Copy Link Nearly half of patients who got a high dose of Eli Lilly’s experimental obesity shot retatrutide lost the equivalent weight of bariatric surgery, sending the drugmaker’s shares up in premarket trading. conglomerates consumers